thyroid cancer

Assessment of residual radioactivity by a comprehensive wireless, wearable device in thyroid cancer patients undergoing radionuclide therapy and comparison with the results of a home device: a feasibility study

Author(s)3: R. Gallachio, D. Scapicchio, A. Nardelli, T. Pellegrino, M. Prisco, P. Mainenti, C. Sirignano, P. Pedicini, G. Storto
Assessment of residual radioactivity by a comprehensive wireless, wearable device in thyroid cancer patients undergoing radionuclide therapy and comparison with the results of a home device: a feasibility study 150 150 IEEE Journal of Translational Engineering in Health and Medicine (JTEHM)

Objective: To investigate the feasibility of using a wireless wearable device (WD) in differentiated thyroid cancer (DTC) patients undergoing radionuclide therapy with I-131 (RAI) and protected hospitalization, this study compared…

read more